Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? (Q47629555)

4 February 2018

title

Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? (English)

1 reference

4 February 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

Tina B Eilertsen

1

1 reference

4 February 2018

Eszter Vanky

series ordinal

2

1 reference

4 February 2018

Sven M Carlsen

series ordinal

3

1 reference

4 February 2018

language of work or name

English

0 references

publication date

12 June 2012

1 reference

4 February 2018

published in

Human Reproduction

1 reference

4 February 2018

volume

27

1 reference

4 February 2018

issue

8

1 reference

4 February 2018

page(s)

2494-2502

1 reference

4 February 2018

The prevalence and features of the polycystic ovary syndrome in an unselected population

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Anti-Müllerian hormone and ovarian dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

The antral follicle count: practical recommendations for better standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Antimüllerian hormone serum levels: a putative marker for ovarian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Current concepts in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Regulation of ovarian function: the role of anti-Müllerian hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Increased prevalence of diabetes and polycystic ovary syndrome in women with a history of preterm birth: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Role of lifestyle modification in the management of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

The journey from the old to the new AMH assay: how to avoid getting lost in the values

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Sex ratio and pregnancy complications according to mode of conception in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

Serum Levels of Anti-Müllerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES213

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DES213

1 reference

4 February 2018

release_wjilanr3qzc4boscc4r5zo7pey

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wjilanr3qzc4boscc4r5zo7pey

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

4 February 2018